Home Business & Finance Ozempic maker Novo Nordisk downgraded to sell after 70%...
Business & Finance

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
Key Points

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday. [Image text:] novo nordisk
Novo Nordisk (ORG) Deutsche Bank (ORG)
Originally published by MarketWatch Read original →